Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
Scope of the Report:
This report focuses on the Veterinary Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Veterinary Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Boehringer Ingelheim GmbH
Bayer AG
Elanco Animal Health (Eli Lilly and Company)
Ceva Sant Animale
Dechra Pharmaceuticals PLC.
Merck Animal Health
Virbac
Vetoquinol
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-Infective
Anti-Inflammatory
Parasiticides
Others
Market Segment by Applications, can be divided into
Companion Animal
Livestock Animal
There are 15 Chapters to deeply display the global Veterinary Drugs market.
Chapter 1, to describe Veterinary Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Veterinary Drugs, with sales, revenue, and price of Veterinary Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Veterinary Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Veterinary Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Veterinary Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Veterinary Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Anti-Infective
1.2.2 Anti-Inflammatory
1.2.3 Parasiticides
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Companion Animal
1.3.2 Livestock Animal
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim GmbH
2.1.1 Business Overview
2.1.1.1 Boehringer Ingelheim GmbH Description
2.1.1.2 Boehringer Ingelheim GmbH Headquarter, Main Business and Finance Overview
2.1.2 Boehringer Ingelheim GmbH Veterinary Drugs Product Introduction
2.1.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Veterinary Drugs Product Information
2.1.3 Boehringer Ingelheim GmbH Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Boehringer Ingelheim GmbH Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Boehringer Ingelheim GmbH Veterinary Drugs Market Share in 2017
2.2 Bayer AG
2.2.1 Business Overview
2.2.1.1 Bayer AG Description
2.2.1.2 Bayer AG Headquarter, Main Business and Finance Overview
2.2.2 Bayer AG Veterinary Drugs Product Introduction
2.2.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Veterinary Drugs Product Information
2.2.3 Bayer AG Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Bayer AG Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Bayer AG Veterinary Drugs Market Share in 2017
2.3 Elanco Animal Health (Eli Lilly and Company)
2.3.1 Business Overview
2.3.1.1 Elanco Animal Health (Eli Lilly and Company) Description
2.3.1.2 Elanco Animal Health (Eli Lilly and Company) Headquarter, Main Business and Finance Overview
2.3.2 Elanco Animal Health (Eli Lilly and Company) Veterinary Drugs Product Introduction
2.3.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Veterinary Drugs Product Information
2.3.3 Elanco Animal Health (Eli Lilly and Company) Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Elanco Animal Health (Eli Lilly and Company) Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Elanco Animal Health (Eli Lilly and Company) Veterinary Drugs Market Share in 2017
2.4 Ceva Sant Animale
2.4.1 Business Overview
2.4.1.1 Ceva Sant Animale Description
2.4.1.2 Ceva Sant Animale Headquarter, Main Business and Finance Overview
2.4.2 Ceva Sant Animale Veterinary Drugs Product Introduction
2.4.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Veterinary Drugs Product Information
2.4.3 Ceva Sant Animale Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Ceva Sant Animale Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Ceva Sant Animale Veterinary Drugs Market Share in 2017
2.5 Dechra Pharmaceuticals PLC.
2.5.1 Business Overview
2.5.1.1 Dechra Pharmaceuticals PLC. Description
2.5.1.2 Dechra Pharmaceuticals PLC. Headquarter, Main Business and Finance Overview
2.5.2 Dechra Pharmaceuticals PLC. Veterinary Drugs Product Introduction
2.5.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Veterinary Drugs Product Information
2.5.3 Dechra Pharmaceuticals PLC. Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Dechra Pharmaceuticals PLC. Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Dechra Pharmaceuticals PLC. Veterinary Drugs Market Share in 2017
2.6 Merck Animal Health
2.6.1 Business Overview
2.6.1.1 Merck Animal Health Description
2.6.1.2 Merck Animal Health Headquarter, Main Business and Finance Overview
2.6.2 Merck Animal Health Veterinary Drugs Product Introduction
2.6.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Veterinary Drugs Product Information
2.6.3 Merck Animal Health Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Merck Animal Health Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Merck Animal Health Veterinary Drugs Market Share in 2017
2.7 Virbac
2.7.1 Business Overview
2.7.1.1 Virbac Description
2.7.1.2 Virbac Headquarter, Main Business and Finance Overview
2.7.2 Virbac Veterinary Drugs Product Introduction
2.7.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Veterinary Drugs Product Information
2.7.3 Virbac Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Virbac Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Virbac Veterinary Drugs Market Share in 2017
2.8 Vetoquinol
2.8.1 Business Overview
2.8.1.1 Vetoquinol Description
2.8.1.2 Vetoquinol Headquarter, Main Business and Finance Overview
2.8.2 Vetoquinol Veterinary Drugs Product Introduction
2.8.2.1 Veterinary Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Veterinary Drugs Product Information
2.8.3 Vetoquinol Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Vetoquinol Veterinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Vetoquinol Veterinary Drugs Market Share in 2017
3 Global Veterinary Drugs Market Competition, by Manufacturer
3.1 Global Veterinary Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Veterinary Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Veterinary Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Veterinary Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Veterinary Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Veterinary Drugs Market Analysis by Regions
4.1 Global Veterinary Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Veterinary Drugs Sales by Regions (2013-2018)
4.1.2 Global Veterinary Drugs Revenue by Regions (2013-2018)
4.2 North America Veterinary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Veterinary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Veterinary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Veterinary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Veterinary Drugs Sales, Revenue and Growth Rate (2013-2018)
5 North America Veterinary Drugs by Countries, Type, Application and Manufacturers
5.1 North America Veterinary Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Veterinary Drugs Sales by Countries (2013-2018)
5.1.2 North America Veterinary Drugs Revenue by Countries (2013-2018)
5.1.3 United States Veterinary Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Veterinary Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Veterinary Drugs Sales and Growth Rate (2013-2018)
5.2 North America Veterinary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Veterinary Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Veterinary Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Veterinary Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Veterinary Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Veterinary Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Veterinary Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Veterinary Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Veterinary Drugs Revenue and Revenue Share by Application (2013-2018)
6 Europe Veterinary Drugs by Countries, Type, Application and Manufacturers
6.1 Europe Veterinary Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Veterinary Drugs Sales by Countries (2013-2018)
6.1.2 Europe Veterinary Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Veterinary Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Veterinary Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Veterinary Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Veterinary Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Veterinary Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Veterinary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Veterinary Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Veterinary Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Veterinary Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Veterinary Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Veterinary Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Veterinary Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Veterinary Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Veterinary Drugs Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Veterinary Drugs by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Veterinary Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Veterinary Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Veterinary Drugs Revenue by Countries (2013-2018)
7.1.3 China Veterinary Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Veterinary Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Veterinary Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Veterinary Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Veterinary Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Veterinary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Veterinary Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Veterinary Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Veterinary Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Veterinary Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Veterinary Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Veterinary Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Veterinary Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Veterinary Drugs Revenue and Revenue Share by Application (2013-2018)
8 South America Veterinary Drugs by Countries, Type, Application and Manufacturers
8.1 South America Veterinary Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Veterinary Drugs Sales by Countries (2013-2018)
8.1.2 South America Veterinary Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Veterinary Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Veterinary Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Veterinary Drugs Sales and Growth Rate (2013-2018)
8.2 South America Veterinary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Veterinary Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Veterinary Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Veterinary Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Veterinary Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Veterinary Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Veterinary Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Veterinary Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Veterinary Drugs Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Veterinary Drugs by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Veterinary Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Veterinary Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Veterinary Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Veterinary Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Veterinary Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Veterinary Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Veterinary Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Veterinary Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Veterinary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Veterinary Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Veterinary Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Veterinary Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Veterinary Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Veterinary Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Veterinary Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Veterinary Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Veterinary Drugs Revenue and Revenue Share by Application (2013-2018)
10 Global Veterinary Drugs Market Segment by Type
10.1 Global Veterinary Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Veterinary Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Veterinary Drugs Revenue and Market Share by Type (2013-2018)
10.2 Anti-Infective Sales Growth and Price
10.2.1 Global Anti-Infective Sales Growth (2013-2018)
10.2.2 Global Anti-Infective Price (2013-2018)
10.3 Anti-Inflammatory Sales Growth and Price
10.3.1 Global Anti-Inflammatory Sales Growth (2013-2018)
10.3.2 Global Anti-Inflammatory Price (2013-2018)
10.4 Parasiticides Sales Growth and Price
10.4.1 Global Parasiticides Sales Growth (2013-2018)
10.4.2 Global Parasiticides Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Veterinary Drugs Market Segment by Application
11.1 Global Veterinary Drugs Sales Market Share by Application (2013-2018)
11.2 Companion Animal Sales Growth (2013-2018)
11.3 Livestock Animal Sales Growth (2013-2018)
12 Veterinary Drugs Market Forecast (2018-2023)
12.1 Global Veterinary Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Veterinary Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Veterinary Drugs Market Forecast (2018-2023)
12.2.2 Europe Veterinary Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Veterinary Drugs Market Forecast (2018-2023)
12.2.4 South America Veterinary Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Veterinary Drugs Market Forecast (2018-2023)
12.3 Veterinary Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Veterinary Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Veterinary Drugs Market Share Forecast by Type (2018-2023)
12.4 Veterinary Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Veterinary Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Veterinary Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Veterinary Drugs Picture
Table Product Specifications of Veterinary Drugs
Figure Global Veterinary Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD M